Journal
BRAIN BEHAVIOR AND IMMUNITY
Volume 106, Issue -, Pages 307-321Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2022.09.009
Keywords
Parkinson?s disease; Microbiota-gut-brain axis; Biomarkers; Metabolomics; Branched-chain amino acids
Categories
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Research and Innovation Fund of the First Affiliated Hospital of Harbin Medical Uni-versity
- Fundamental Research Fund for Heilongjiang Universities
- [62072143]
- [81271208]
- [2021M693825]
- [2021B17]
- [2022-KYYWF]
Ask authors/readers for more resources
Neuroinflammation caused by gut microbiota disorder and its metabolites is involved in the development of Parkinson's disease (PD). This study found that a high BCAA diet intervention could attenuate inflammation levels, improve motor and non-motor dysfunctions, and protect dopaminergic neurons in a PD mouse model.
Neuroinflammation caused by the disorder of gut microbiota and its metabolites is associated with the patho-genesis of Parkinson's disease (PD). Thus, it is necessary to identify certain molecules derived from gut micro-biota to verify whether they could become intervention targets for the treatment of PD. The branched-chain amino acids (BCAAs), as a common dietary supplement, could modulate brain function. Herein, we investigated the longitudinal shifts of microbial community in mice treated with rotenone for 0, 3 and 4 weeks by 16S rRNA gene sequencing to identify the microbial markers at different PD stages. Serum BCAAs were determined by gas chromatography-mass spectrometry. Then, rotenone-induced mice were given a high BCAA diet to evaluate the motor and non-motor functions, dopaminergic neuron loss, and inflammation levels. Using a PD mouse model, we discovered that during PD progression, the alterations of gut microbiota compositions led to the peripheral decrease of BCAAs. Based on the serum lipopolysaccharide binding protein concentrations and the levels of pro-inflammatory factors (including tumor necrosis factor-alpha, interleukin [IL]-1 beta, and IL-6) in the colon and substantia nigra, we found that the high BCAA diet could attenuate the inflammatory levels in PD mice, and reverse motor and non-motor dysfunctions and dopaminergic neuron impairment. Together, our results emphasize the dynamic changes of gut microbiota and BCAA metabolism and propose a novel strategy for PD therapy: a high BCAA diet intervention could improve PD progression by regulating the levels of inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available